| scholarly article | Q13442814 |
| P50 | author | Dominique Heymann | Q43131742 |
| P2093 | author name string | D Scherman | |
| J Rousseau | |||
| F Rédini | |||
| P Perrot | |||
| V Escriou | |||
| C Charrier | |||
| V Trichet | |||
| G Picarda | |||
| P2860 | cites work | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 |
| Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment | Q30444637 | ||
| Molecular biology of bone metastasis | Q30444749 | ||
| Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma | Q33215107 | ||
| Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression | Q33944735 | ||
| Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. | Q34169244 | ||
| Osteosarcoma (osteogenic sarcoma). | Q34574274 | ||
| Clinical development of anti-RANKL therapy | Q35901092 | ||
| Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expression | Q35991706 | ||
| Prospects of RNA interference therapy for cancer | Q36337922 | ||
| Harnessing in vivo siRNA delivery for drug discovery and therapeutic development | Q36396538 | ||
| Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies. | Q36731426 | ||
| Delivery vehicles for small interfering RNA in vivo | Q37079140 | ||
| The business of RNAi therapeutics | Q37147185 | ||
| Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma | Q37409192 | ||
| siRNA and innate immunity | Q37481215 | ||
| Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation | Q39949251 | ||
| Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo | Q40076863 | ||
| An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma | Q40185368 | ||
| Regulation of cancer cell migration and bone metastasis by RANKL. | Q40298349 | ||
| Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma | Q40365729 | ||
| Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model | Q40394237 | ||
| Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3. | Q40505562 | ||
| Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases | Q40701638 | ||
| Predictive value of serum immunosuppressive acidic protein for lung metastasis after amputation of murine osteosarcoma of the lower limb | Q40878264 | ||
| Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute | Q43754201 | ||
| High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter | Q45732758 | ||
| Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption | Q45869910 | ||
| RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts | Q48472950 | ||
| A new experimental rat model of osteosarcoma established by intrafemoral tumor cell inoculation, useful for biology and therapy investigations. | Q54657762 | ||
| Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma | Q77337118 | ||
| Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis | Q83856360 | ||
| How to make siRNA lipoplexes efficient? Add a DNA cargo | Q84483901 | ||
| P433 | issue | 6 | |
| P921 | main subject | bioluminescence | Q179924 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 387-397 | |
| P577 | publication date | 2010-01-15 | |
| P1433 | published in | Cancer Gene Therapy | Q15763088 |
| P1476 | title | Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models | |
| P478 | volume | 17 |
| Q37711784 | Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta |
| Q52370993 | Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma. |
| Q28547031 | Development of a cell-based bioassay for phospholipase A2-triggered liposomal drug release |
| Q34540997 | Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model |
| Q36127335 | In vivo bioluminescence imaging for leptomeningeal dissemination of medulloblastoma in mouse models |
| Q59800904 | Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma |
| Q36661456 | Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status |
| Q55364642 | Morphological Analysis of Trafficking and Processing of Anionic and Cationic Liposomes in Cultured Cells. |
| Q38112726 | Multimodality imaging of RNA interference |
| Q38089102 | Non-invasive molecular imaging for preclinical cancer therapeutic development. |
| Q34544842 | Optical imaging in vivo with a focus on paediatric disease: technical progress, current preclinical and clinical applications and future perspectives |
| Q36491545 | Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL |
| Q35652081 | Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate |
| Q38349935 | Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal |
| Q30409592 | Subcutaneous administration of D-luciferin is an effective alternative to intraperitoneal injection in bioluminescence imaging of xenograft tumors in nude mice |
| Q36963424 | ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis |
Search more.